| Current Price | $11.64 | Mkt Cap | $720.22M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 29.10 |
| Prev. Close | $11.64 | Div. (Yield) | N/A (N/A) |
| Daily Range | $11.61 - $12.23 | Volume | 422,534 |
| 52-Wk Range | $2.50 - $12.23 | Avg. Daily Vol. | 463,000 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from members about IPXL.
Recs
fourthreethree
(54.35)
Submitted: 10/12/2009 3:04:16 PM :
Start Price:
$9.27
IPXL Score:
+22.95
just ignoring advice and following my brain's "gut."
Recs
soho48
(51.02)
Submitted: 2/24/2009 2:05:56 AM :
Start Price:
$5.27
IPXL Score:
+71.67
New propriatary drugs are being developed and more first to file generics are filed with the FDA. Generics are a safer place with this administration.
Find the members with the highest scoring picks in IPXL.
soho48 (51.02) Score: +71.67
The Score Leader is the member with the highest score across all their picks in IPXL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| soho48 | 51.02 | 2/24/2009 |
|
3Y | $5.27 | +120.87% | +49.21% | +71.67 | 1 Comment | |
| SSPX9 | 99.55 | 5/26/2009 |
|
NS | $6.16 | +88.96% | +26.22% | +62.74 | ||
| SSPX911 | 99.22 | 5/14/2009 |
|
NS | $6.20 | +87.74% | +25.71% | +62.03 | ||
| WatchMeNow | 68.67 | 5/18/2009 |
|
NS | $6.65 | +75.04% | +24.54% | +50.49 | ||
| MaximumDamage | 93.67 | 5/18/2009 |
|
NS | $6.65 | +75.04% | +24.54% | +50.49 | ||
| DrRetardles | 50.27 | 8/28/2009 |
|
1Y | $7.75 | +50.19% | +7.52% | +42.67 | ||
| manor1730 | 27.01 | 8/19/2009 |
|
5Y | $7.53 | +54.58% | +12.81% | +41.77 | ||
| LehmanBrosRIP | 72.77 | 6/15/2009 |
|
5Y | $7.32 | +59.02% | +18.70% | +40.31 | ||
| AlwaysOceanside | 87.89 | 6/15/2009 |
|
5Y | $7.32 | +59.02% | +18.70% | +40.31 | ||
| SSPX0 | 93.53 | 6/8/2009 |
|
5Y | $7.35 | +58.37% | +18.85% | +39.52 |
See what the Wall Street professionals think, according to their public statements and filings.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK